Torley Helen sold HALO
May 12, 2026 · Form 4 insider transaction
Torley Helen sold 100 shares of Halozyme Therapeutics, Inc. at $67.85 per share, a transaction worth $6.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$67.85
Total value
$6.8K
InsiderTorley Helen
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 12, 2026
Filing dateMay 13, 2026
Shares owned after787,680
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.